Cited by 257Metabolism and Genetic DisordersMitochondrial Function and PathologyNeurological diseases and metabolism

The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.

Disorders of mitochondrial fatty acyl‐CoA β‐oxidation

Wanders, R. J. A., Vreken, P., den Boer, M. E. J., Wijburg, F. A., Van Gennip, A. H., IJlst, L.·1999·Journal of Inherited Metabolic Disease

Abstract

In recent years tremendous progress has been made with respect to the enzymology of the mitochondrial fatty acid β‐oxidation machinery and defects therein. Firstly, a number of new mitochondrial β‐oxidation enzymes have been identified, including very‐long‐chain acyl‐CoA dehydrogenase (VLCAD) and mitochondrial trifunctional protein (MTP). Secondly, the introduction of tandem MS for the analysis of plasma acylcarnitines has greatly facilitated the identification of patients with a defect in fatty acid oxidation (FAO). These two developments explain why the number of defined FAO disorders has increased dramatically, making FAO disorders the most rapidly growing group of inborn errors of metabolism. In this review we describe the current state of knowledge of the enzymes involved in the mitochondrial oxidation of straight‐chain, branched‐chain and (poly)unsaturated fatty acyl‐CoAs as well as disorders of fatty acid oxidation. The laboratory diagnosis of these disorders is described, with particular emphasis on the methods used to identify the underlying enzyme defect and the molecular mutations. In addition, a simple flowchart is presented as a guide to the identification of mitochondrial FAO‐disorders. Finally, treatment strategies are discussed briefly.

Overview

Integrity signals

Registry

Crossref · 10.1023/a:1005504223140

Cites

180 of 180 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with inborn errors of metabolism present with nonketotic hypoglycemia, muscle weakness, elevated long-chain acylcarnitines, and systemic carnitine depletion.

    “Patients afflicted with these disorders present with nonketotic hypoglycemia, muscle weakness, pronounced elevations in long chain acylcarnitines and systemic carnitine depletion [91].”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. VredendaalPJ van denBergIET StroobantsAK Van DerADL MalingreHE BergerR(1999)Structural organisation of the human short‐chainL‐3‐hydroxyacyl‐CoA dehydrogenase gene.Mamm Genome(in press)..

Cited by

Sorted by citations

Metadata

Authors
Wanders, R. J. A., Vreken, P., den Boer, M. E. J., Wijburg, F. A., Van Gennip, A. H., & IJlst, L.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Departments of Clinical Chemistry Academic Medical Center, University of Amsterdam The Netherlands
Corresponding author
Wanders, R. J. A.
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
1999-06
Volume
22
Issue
4
Pages
442-487
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W2147457396
Cited by
257
References
180
Citations by year
2026: 1 · 2025: 2 · 2024: 12 · 2023: 4 · 2022: 9 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 12 · 2013: 13 · 2012: 5
FWCI
1.97
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Inherited Metabolic Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
fatty acid beta-oxidation disorders, inborn errors of metabolism, VLCAD, mitochondrial trifunctional protein, acylcarnitines, tandem mass spectrometry, branched-chain fatty acids, polyunsaturated fatty acids, enzyme defects, molecular diagnosis, treatment options
MeSH terms
Acyl Coenzyme A, Fatty Acids, Fatty Acids, Unsaturated, Humans, Lipid Metabolism, Inborn Errors, Mitochondria, Oxidation-Reduction, Prenatal Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review